Cargando…

Cannabis use in gynecologic cancer patients in a Canadian cancer center

OBJECTIVE: The primary objective of this study was to estimate the prevalence of cannabis use in patients with gynecologic malignancies and to describe patterns of cannabis use. Secondary objectives included identifying sources of cannabis information used by patients. METHODS: This is a single inst...

Descripción completa

Detalles Bibliográficos
Autores principales: Black, Kristin A., Bowden, Sylvie, Thompson, Mary, Ghatage, Prafull
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236193/
https://www.ncbi.nlm.nih.gov/pubmed/37273764
http://dx.doi.org/10.1016/j.gore.2023.101210
_version_ 1785052860383232000
author Black, Kristin A.
Bowden, Sylvie
Thompson, Mary
Ghatage, Prafull
author_facet Black, Kristin A.
Bowden, Sylvie
Thompson, Mary
Ghatage, Prafull
author_sort Black, Kristin A.
collection PubMed
description OBJECTIVE: The primary objective of this study was to estimate the prevalence of cannabis use in patients with gynecologic malignancies and to describe patterns of cannabis use. Secondary objectives included identifying sources of cannabis information used by patients. METHODS: This is a single institution cross sectional survey conducted in Calgary, Alberta. Patients with a current or prior gynecologic cancer diagnosis were considered for inclusion. Planned analysis included descriptive statistics of patient demographics, and the patterns of cannabis use were described using frequencies and proportions. RESULTS: Forty-six patients participated in the survey. The most common disease sites were ovarian cancer and uterine cancer, with the majority of patients receiving chemotherapy as part of their treatment (n = 35). Seventeen participants were current cannabis users (37%). The most common symptoms participants used cannabis for were pain (9/17), anxiety (9/17), and insomnia (9/17). Most patients using cannabis did not have a prescription and obtained their cannabis from a recreational dispensary (11/17). Many participants using cannabis had not talked to their doctor about cannabis (9/17). Instead, the most common sources of information about cannabis were cannabis retailers (20/46), and friends/family (20/46). Over 50% of patients would be interested in discussing cannabis if their physician broached the subject (26/46). CONCLUSIONS: The results from this survey indicate that patients would like to talk to their oncologist about cannabis. Further research is needed to inform physician training and direct patient education to ensure that patients have access to unbiased, evidence-based information to make decisions about cannabis use.
format Online
Article
Text
id pubmed-10236193
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102361932023-06-03 Cannabis use in gynecologic cancer patients in a Canadian cancer center Black, Kristin A. Bowden, Sylvie Thompson, Mary Ghatage, Prafull Gynecol Oncol Rep Research Report OBJECTIVE: The primary objective of this study was to estimate the prevalence of cannabis use in patients with gynecologic malignancies and to describe patterns of cannabis use. Secondary objectives included identifying sources of cannabis information used by patients. METHODS: This is a single institution cross sectional survey conducted in Calgary, Alberta. Patients with a current or prior gynecologic cancer diagnosis were considered for inclusion. Planned analysis included descriptive statistics of patient demographics, and the patterns of cannabis use were described using frequencies and proportions. RESULTS: Forty-six patients participated in the survey. The most common disease sites were ovarian cancer and uterine cancer, with the majority of patients receiving chemotherapy as part of their treatment (n = 35). Seventeen participants were current cannabis users (37%). The most common symptoms participants used cannabis for were pain (9/17), anxiety (9/17), and insomnia (9/17). Most patients using cannabis did not have a prescription and obtained their cannabis from a recreational dispensary (11/17). Many participants using cannabis had not talked to their doctor about cannabis (9/17). Instead, the most common sources of information about cannabis were cannabis retailers (20/46), and friends/family (20/46). Over 50% of patients would be interested in discussing cannabis if their physician broached the subject (26/46). CONCLUSIONS: The results from this survey indicate that patients would like to talk to their oncologist about cannabis. Further research is needed to inform physician training and direct patient education to ensure that patients have access to unbiased, evidence-based information to make decisions about cannabis use. Elsevier 2023-05-25 /pmc/articles/PMC10236193/ /pubmed/37273764 http://dx.doi.org/10.1016/j.gore.2023.101210 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Report
Black, Kristin A.
Bowden, Sylvie
Thompson, Mary
Ghatage, Prafull
Cannabis use in gynecologic cancer patients in a Canadian cancer center
title Cannabis use in gynecologic cancer patients in a Canadian cancer center
title_full Cannabis use in gynecologic cancer patients in a Canadian cancer center
title_fullStr Cannabis use in gynecologic cancer patients in a Canadian cancer center
title_full_unstemmed Cannabis use in gynecologic cancer patients in a Canadian cancer center
title_short Cannabis use in gynecologic cancer patients in a Canadian cancer center
title_sort cannabis use in gynecologic cancer patients in a canadian cancer center
topic Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236193/
https://www.ncbi.nlm.nih.gov/pubmed/37273764
http://dx.doi.org/10.1016/j.gore.2023.101210
work_keys_str_mv AT blackkristina cannabisuseingynecologiccancerpatientsinacanadiancancercenter
AT bowdensylvie cannabisuseingynecologiccancerpatientsinacanadiancancercenter
AT thompsonmary cannabisuseingynecologiccancerpatientsinacanadiancancercenter
AT ghatageprafull cannabisuseingynecologiccancerpatientsinacanadiancancercenter